000538 云南白药
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.86112.06810.4467.8227.354
总资产报酬率 ROA (%)3.6118.9027.6445.6815.216
投入资产回报率 ROIC (%)4.32910.5248.8746.5436.141

边际利润分析
销售毛利率 (%)31.55527.89826.50626.32327.150
营业利润率 (%)20.80314.26712.3519.2399.582
息税前利润/营业总收入 (%)20.72413.81111.6568.3158.862
净利润/营业总收入 (%)17.77911.90810.5417.7847.691

收益指标分析
经营活动净收益/利润总额(%)92.64684.90383.614130.329133.101
价值变动净收益/利润总额(%)11.68116.07418.7337.353-25.414
营业外收支净额/利润总额(%)0.030-0.473-0.2590.169-0.101

偿债能力分析
流动比率 (X)2.8952.6562.8512.6313.578
速动比率 (X)2.4072.1662.3452.0422.919
资产负债率 (%)24.80626.54925.80527.74526.560
带息债务/全部投入资本 (%)7.3639.18611.20513.75713.885
股东权益/带息债务 (%)1,221.735959.228770.454607.468602.950
股东权益/负债合计 (%)302.927276.421287.336260.266275.012
利息保障倍数 (X)-244.097-35.545-17.585-8.849-12.480

营运能力分析
应收账款周转天数 (天)86.53289.42887.70080.28253.141
存货周转天数 (天)74.37979.42590.395109.623131.575